Priority Date: 26.01.12 (FR 20120050768)

PYRIMIDOOXAZOCINE DERIVATIVES AS MTOR - INHIBITORS

  • Application ID: EP13712331
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
2 offices
Technology Company
Company dna nony
no operation time available
1099.06
1 office
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Sanofi is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 232 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 26.01.2012 - Priority Date (FR 20120050768)
  • 01.08.2013 - Publication A1 (WO2013111106)
  • 03.12.2014 - Publication A1 (EP2807172)
  • 30.11.2016 - Publication B1 (EP2807172)

IPC Classification